Dover's CPC Biotech Launches Quattroflow HTX Pump Drive
Dover Corporation's subsidiary, CPC Biotech, has introduced the Quattroflow HTX, an all-in-one pump drive designed for biopharmaceutical processing.
Stocks · News reference
Filed: 2026-11-02 AccNo: 0001193125-26-442782 Size: 832 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Dover Corporation's subsidiary, CPC Biotech, has introduced the Quattroflow HTX, an all-in-one pump drive designed for biopharmaceutical processing.
Mediobanca Research raised its target price for doValue from 2.13 to 2.22 euros while maintaining a 'neutral' rating.
doValue announced strong third-quarter growth, with revenue rising 46% year-over-year to €180 million and adjusted EBITDA increasing 70% to €65 million.
Dover Corporation's Board of Directors has declared a regular quarterly cash dividend of $0.525 per share, payable on December 15, 2026.
Dover completed cash tender offers to repurchase up to $300 million of its outstanding debt securities across four series of notes and debentures. The company accepted all tenders for the first three series (6.650% Debentures due 2028, 6.600% Notes due 2038, and 5.375% Debentures due 2035) totaling approximately $277.6 million, and applied a 12.64% proration factor to the 5.375% Notes due 2041. Settlement is expected on November 9, 2026.
Dover Corporation has finalized the acquisition of Leistung Engineering Pvt. Ltd., which will be integrated into the OPW Fluid Transfer Solutions business unit.